Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non‐human primate studies and clinical trials. - Nicholls, Stephen J.; Nelson, Adam J.; Kastelein, John J. P.; Ditmarsch, Marc; Hsieh, Andrew; Johnson, Judith; Curcio, Danielle; Kling, Douglas; Kirkpatrick, Carol F.; Davidson, Michael H. (Pharmacology Research & Perspectives, 2024)